NCT06677645

Brief Summary

Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
258

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Nov 2024

Typical duration for all trials

Geographic Reach
1 country

10 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Nov 2024Nov 2027

First Submitted

Initial submission to the registry

October 23, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 7, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

November 20, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2027

Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

October 23, 2024

Last Update Submit

June 10, 2025

Conditions

Keywords

social careTempory hospitalizationElderly peopleMedical caremedical-economic study

Outcome Measures

Primary Outcomes (1)

  • Study to investigate the impact of HTSH on length of hospital stay in referring services

    The main assessment criterion is based on the average length of stay observed at the end of the study, compared with that of the previous two years, 2021 and 2022, in the referring services.

    24 months

Secondary Outcomes (4)

  • Analysis of pathways and plans for returning home

    24 months

  • Analysis of HTSH patient profiles a) Proportion of eligible patients and their comorbidities b) Social profile + main reason for hospitalization of patients admitted to HTSH

    24 months

  • Analysis of discharges and patient outcomes

    24 months

  • Quality of life and caregiver benefit analysis

    24 months

Study Arms (2)

Prospective group

258 subjects in the prospective group

Retrospective group

Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

258 subjects in the prospective group. Retrospective data will be collected directly from hospital departments by ARS IDF or from physicians responsible for medical information (RMI) within each hospital center participating in the study, for the 2 years 2021 and 2022 prior to the study and compared with the average length of stay for services to be calculated at the end of the study.

You may qualify if:

  • Patient selection criteria
  • Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital,
  • Oral expression of non opposition to participation in the study, documented in the medical record by the physician,
  • Presenting a defined and feasible plan for returning home,
  • Whose social/medical situation (stabilized) does not allow an immediate return home after hospitalization.
  • Caregiver selection criteria
  • Person with an unpaid caregiving activity for their relative in HTSH,
  • Person verbally expressing their non-opposition to participating in the study, and documented in the medical record of the patient they are helping,
  • A person who is able to understand the study questionnaires and evaluations, and is able to answer them without the help of a third party.
  • Professional selection criteria
  • Salaried professional, nursing or not, regularly and directly involved in the HTSH circuit, whether in hospital or in nursing home / long term care units, for at least 6 months,
  • Oral expression of non opposition to participation in the study, documented by the establishment.
  • Be already included in another clinical study,
  • Benefit from a legal protection measure or be unable to express their consent, in accordance with article L1121-8 of the French Public Health Code.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Résidence ZEMGOR

Cormeilles-en-Parisis, 95240, France

NOT YET RECRUITING

EHPAD Pierre TABANOU

L'Haÿ-les-Roses, 94240, France

RECRUITING

Groupe Hospitalier Sud Ile de France (GHSIF)

Melun, 77000, France

NOT YET RECRUITING

GHU Lariboisière

Paris, 75010, France

NOT YET RECRUITING

Broca Hospital

Paris, 75013, France

RECRUITING

USDL Vaugirard, APHP

Paris, 75015, France

RECRUITING

Centre Hospitalier de Rambouillet

Rambouillet, 78514, France

NOT YET RECRUITING

Centre Hospitalier de Versailles

Versailles, 78157, France

ACTIVE NOT RECRUITING

Hopital Paul Brousse

Villejuif, 94800, France

NOT YET RECRUITING

CHU Bicêtre

Paris, Île-de-France Region, 94270, France

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2024

First Posted

November 7, 2024

Study Start

November 20, 2024

Primary Completion (Estimated)

November 20, 2026

Study Completion (Estimated)

November 20, 2027

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations